Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-016476
Filing Date
2025-06-03
Accepted
2025-06-03 16:24:21
Documents
1
Period of Report
2025-06-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6000
  Complete submission text file 0001127602-25-016476.txt   7727
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Issuer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMARIN CORPORATION PLC 77 SIR JOHN ROGERSON'S QUAY, BLOCK C DUBLIN 2 L2 D02 VK60
Business Address
Sullivan Diane E. (Reporting) CIK: 0001968736 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30111 | Film No.: 251019898